Skip to main navigation
Skip to search
Skip to main content
Hong Kong Baptist University Home
Help & FAQ
Link opens in a new tab
Search content at Hong Kong Baptist University
Home
Scholars
Departments / Units
Research Output
Projects / Grants
Prizes / Awards
Activities
Press/Media
Student theses
Datasets
Transketolase counteracts oxidative stress to drive cancer development
Iris Ming Jing Xu
, Robin Kit Ho Lai
, Shuhai Lin
, Aki Pui Wah Tse
, David Kung Chun Chiu
, Hui Yu Koh
, Cheuk Ting Law
, Chun Ming Wong
,
Zongwei Cai
, Carmen Chak Lui Wong
*
, Irene Oi Lin Ng
*
*
Corresponding author for this work
Chinese Medicine - Clinical Division
Department of Chemistry
State Key Laboratory of Environmental and Biological Analysis
Research output
:
Contribution to journal
›
Journal article
›
peer-review
227
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Transketolase counteracts oxidative stress to drive cancer development'. Together they form a unique fingerprint.
Sort by:
Weight
Alphabetically
Keyphrases
Oxidative Stress
100%
Cancer Development
100%
Transketolase
100%
Cancer Cells
75%
Antioxidant
75%
Pentose Phosphate Pathway
50%
Cancer Growth
50%
Knockdown
25%
Nicotinamide Adenine Dinucleotide Phosphate (NADPH)
25%
Redox Homeostasis
25%
Pharmacological Inhibitors
25%
Pathways in Cancer
25%
Stress Sensor
25%
Therapeutic Benefits
25%
Nuclear Factor Erythroid 2-like 2
25%
Kelch-like
25%
Targeted Therapy
25%
NAPDH
25%
Biochemical Pathways
25%
Sorafenib
25%
Medicine and Dentistry
Malignant Neoplasm
100%
Oxidative Stress
100%
Transketolase
100%
Cancer Cell
75%
Antioxidant
75%
Hexose Monophosphate Shunt
50%
Pentose Phosphate Cycle
50%
Cancer Growth
50%
Homeostasis
25%
Synapsin I
25%
Cancer
25%
Nuclear Factor
25%
Reduced Nicotinamide Adenine Dinucleotide Phosphate
25%
Targeted Therapy
25%
Sorafenib
25%
Biochemistry, Genetics and Molecular Biology
Oxidative Stress
100%
Transketolase
100%
Cancer Cell
75%
Hexose Monophosphate Shunt
50%
Genetics
25%
Enzyme
25%
Synapsin I
25%
Homeostasis
25%
Sorafenib
25%
Targeted Therapy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Transketolase
100%
Antioxidant
75%
Pentose Phosphate
50%
Cancer Growth
50%
Nuclear Factor
25%
Reduced Nicotinamide Adenine Dinucleotide Phosphate
25%
Synapsin I
25%
Sorafenib
25%